Dominican Republic vs Trinidad and Tobago: Hepatitis B surface antigen (HBsAg) prevalence
Dominican Republic
0.1%
in 2024
Trinidad and Tobago
0.1%
in 2024
Dominican Republic rank
101st
Trinidad and Tobago rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Dominican Republic
- Trinidad and Tobago
How they compare
Dominican Republic currently reports 0.1% against 0.1% in Trinidad and Tobago, a difference of 0.0%.
Across all 10 years both countries report, Trinidad and Tobago has been ahead every year.
Dominican Republic ranks 101st and Trinidad and Tobago ranks 101st of 194 countries.
Trinidad and Tobago has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Dominican Republic | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.2% | 0.0% | Trinidad and Tobago |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Dominican Republic or Trinidad and Tobago?
- Dominican Republic, at 0.1% against 0.1% in Trinidad and Tobago as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Dominican Republic and Trinidad and Tobago?
- 0.0%, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Trinidad and Tobago?
- 10 years are reported by both, from 2015 to 2024.
- How do Dominican Republic and Trinidad and Tobago rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Dominican Republic ranks 101st and Trinidad and Tobago ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.